PACS Group, Inc. (NYSE:PACS) Stock Has Average Price Target of $61.33 According to Analysts

Key Points

• Analysts are broadly bullish: PACS Group has a “Moderate Buy” consensus, with seven Buy ratings and one Hold; the average 12-month price target is $61.33.
• Quarterly results beat estimates: PACS reported EPS of $0.63 and revenue of $1.50 billion, and raised its 2026 revenue and adjusted EBITDA outlook.
• Insiders have sold shares: Executives sold shares under pre-arranged Rule 10b5-1 plans, while retaining substantial ownership; insiders hold 70.1% of the stock.

Shares of PACS Group, Inc. (NYSE:PACS - Get Free Report) have earned an average recommendation of "Moderate Buy" from the eight research firms that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $61.33.

A number of analysts have issued reports on PACS shares. Truist Financial reiterated a "buy" rating and issued a $65.00 price target (up from $62.00) on shares of PACS Group in a report on Thursday. UBS Group upped their price target on shares of PACS Group from $60.00 to $67.00 and gave the stock a "buy" rating in a research report on Thursday. Wall Street Zen downgraded PACS Group from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 8th. Zacks Research lowered PACS Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, September 9th. Finally, Weiss Ratings upgraded PACS Group from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday.

Insider Buying and Selling

In other news, CAO Michelle Lewis sold 3,172 shares of the business's stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $50.06, for a total value of $158,790.32. Following the transaction, the chief accounting officer owned 340,338 shares of the company's stock, valued at approximately $17,037,320.28. The trade was a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jason Murray sold 167,434 shares of PACS Group stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $50.24, for a total transaction of $8,411,884.16. Following the sale, the chief executive officer owned 53,954,101 shares of the company's stock, valued at $2,710,654,034.24. The trade was a 0.31% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 1,762,431 shares of company stock worth $80,686,053. 70.10% of the stock is owned by insiders.

Institutional Investors Weigh In On PACS Group

Several institutional investors have recently added to or reduced their stakes in PACS. Financial Management Professionals Inc. increased its holdings in PACS Group by 54.9% in the second quarter. Financial Management Professionals Inc. now owns 663 shares of the company's stock valued at $28,000 after purchasing an additional 235 shares during the period. Eurizon Capital SGR S.p.A. purchased a new position in PACS Group in the 3rd quarter worth approximately $34,000. GK Wealth Management LLC bought a new stake in PACS Group during the 3rd quarter valued at about $41,000. KBC Group NV acquired a new position in PACS Group during the 1st quarter valued at approximately $42,000. Finally, USA Financial Formulas purchased a new stake in PACS Group in the 3rd quarter worth $46,000.

PACS Group Stock Performance

NYSE:PACS opened at $49.68 on Friday. PACS Group has a 1-year low of $10.31 and a 1-year high of $51.68. The stock has a market cap of $7.86 billion, a P/E ratio of 28.07, a PEG ratio of 1.42 and a beta of -0.14. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a 50-day moving average of $44.64 and a two-hundred day moving average of $40.03.

PACS Group (NYSE:PACS - Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.58 by $0.05. The firm had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.46 billion. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. On average, research analysts expect that PACS Group will post 2.13 earnings per share for the current fiscal year.

PACS Group News Summary

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: Quarterly results beat expectations and outlook rose. PACS reported Q3 EPS of $0.63 and revenue of $1.50 billion, topping estimates; adjusted EBITDA increased 33.6%. Management raised its 2026 revenue forecast to $5.95–$6.05 billion and adjusted EBITDA outlook to $685–$695 million. Q3 earnings coverage Raised 2026 outlook
• Positive Sentiment: Expansion and facility ramp-ups may support continued growth. Recent acquisitions in Florida and Texas, along with the Eduro deal, add about 8,400 beds. Company leaders cited occupancy near 90%, while newer facilities mature and move toward higher occupancy and patient acuity. Acquisitions and results Occupancy and acquisitions
• Positive Sentiment: Analysts raised targets and maintained bullish ratings. Truist lifted its target to $65 and kept Buy; Stephens raised its target to $64 with an Overweight rating. UBS also raised its target to $67 and maintained Buy. Truist target update Stephens forecast
• Negative Sentiment: Executives and a director disclosed stock sales. CEO Jason Murray and director Mark Hancock sold shares, as did the CAO. The transactions were made under pre-arranged Rule 10b5-1 plans, and the CEO and director retained substantial holdings, which may temper concerns. Director sale CEO sale

PACS Group Company Profile

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company's operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.